Natixis Advisors LLC Grows Position in NeoGenomics, Inc. (NASDAQ:NEO)
Natixis Advisors LLC increased its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 8.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 36,976 shares of the medical research company’s stock after purchasing an additional 2,994 shares during the period. Natixis […]
Natixis Advisors LLC increased its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 8.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 36,976 shares of the medical research company’s stock after purchasing an additional 2,994 shares during the period. Natixis […]
